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Resorcylic acid lactones (RAL) and dihydroxyphenylacetic acid
lactones (DAL) represent important pharmacophores with heat
shock response and immune system modulatory activities. The
biosynthesis of these fungal polyketides involves a pair of collab-
orating iterative polyketide synthases (iPKSs): a highly reducing
iPKS (hrPKS) whose product is further elaborated by a nonreduc-
ing iPKS (nrPKS) to yield a 1,3-benzenediol moiety bridged by
a macrolactone. Biosynthesis of unreduced polyketides requires
the sequestration and programmed cyclization of highly reac-
tive poly-β-ketoacyl intermediates to channel these uncommitted,
pluripotent substrates towards defined subsets of the polyketide
structural space. Catalyzed by product template (PT) domains of
the fungal nrPKSs and discrete aromatase/cyclase enzymes in
bacteria, regiospecific first-ring aldol cyclizations result in charac-
teristically different polyketide folding modes. However, a few
fungal polyketides, including the DAL dehydrocurvularin, derive
from a folding event that is analogous to the bacterial folding
mode. The structural basis of such a drastic difference in the way
a PT domain acts has not been investigated until now. We report
here that the fungal versus the bacterial folding mode difference
is portable upon creating hybrid enzymes, and structurally char-
acterize the resulting unnatural products. Using structure-guided
active site engineering, we unravel structural contributions to
regiospecific aldol condensations, and show that reshaping the
cyclization chamber of a PT domain by only three selected point
mutations is sufficient to reprogram the dehydrocurvularin nrPKS
to produce polyketides with a fungal fold. Such rational control of
first ring cyclizations will facilitate efforts towards the engineered
biosynthesis of novel chemical diversity from natural unreduced
polyketides.
biosynthesis j cyclase j iterative catalysis j natural products j polyke-
tides
Introduction
Fungal polyketides are one of the largest families of structurally
diverse natural products with antibiotic, antiproliferative, im-
munosuppressive, and enzyme inhibitory activities. Importantly,
they also provide lead compounds and inspiration for pharma-
ceutical drug discovery, as evidenced by the statin cholesterol-
lowering agents (1, 2). Fungal polyketides are biosynthesized by
multi-domain megasynthases (Type I iterative polyketide syn-
thases, iPKSs) that employ ketoacyl synthase (KS), acyl trans-
ferase (AT), and acyl carrier protein (ACP) domains to catalyze
recursive thio-Claisen condensations using malonyl-CoA exten-
der units. While the architecture of these enzymes is similar
to a single module of the bacterial Type I modular PKSs (3),
fungal iPKSs use a single set of active sites iteratively, analogous
to dissociated bacterial type II PKSs (4). Fungal iPKSs may
be classified into three subgroups (5). Highly reducing iPKSs
(hrPKSs) generate complex linear or non-aromatic cyclic prod-
ucts by reducing the nascent β-ketoacyl intermediates to the
β-alcohol, the alkene, or the alkane after each condensation
step, using their ketoreductase (KR), dehydratase (DH), and
enoyl reductase (ER) domains to execute a cryptic biosynthetic
program (2, 6-8). Partially reducing iPKSs omit enoyl reduction
to generate simple cyclic structures (5). Finally, nonreducing
iPKSs (nrPKSs) feature no reducing domains, and generate a
wide variety of aromatic products. nrPKSs select different starter
units by a starter unit:ACP transacylase (SAT) domain (9), and
mold the polyketide chains into cyclic products by regiospecific
cyclizations. First-ring cyclizations are catalyzed by the product
template domains (PT) (10), while the polyketide chains are
terminated by Claisen cyclase (11), macrolactone synthase (12)
(thioesterase, TE) or reductive release (R) domains (2).
While the biosynthesis of most fungal polyketides requires a
single iPKS enzyme, the assembly of the resorcylic acid lactones
(RALs) involves a pair of collaborating hrPKS and nrPKS, acting
in sequence (12-17). Fungal RALs are rich pharmacophores with
estrogen agonist (zearalenone), mitogen-activated protein kinase
inhibitory (hypothemycin), and heat shock response modulatory
activities (radicicol and monocillin II (1), Fig. 1) (18, 19). For
these RALs, the hrPKS produces a reduced linear polyketide
chain that is directly transferred to the nrPKS (9). The nrPKS fur-
ther extends the polyketide, closes the first 6-membered ring by
aldol condensation, and releases the RAL product by macrolac-
tone formation (Fig. 1). We have recently shown that the assem-
bly of 10,11-dehydrocurvularin (2), a phytotoxic dihydroxypheny-
lacetic acid lactone (DAL) from Aspergillus terreus, employs a
similar chemical modularity principle (20). Curvularins modulate
the mammalian immune system by repressing the inducible nitric
oxide synthase (iNOS) (21, 22). In addition, bothmonocillin II (1)
and 10,11-dehydrocurvularin (2) act as promising broad spectrum
inhibitors of various cancer cell lines in vitro by overwhelming the
heat shock response, an evolutionarily conserved coping mecha-
nism of eukaryotic cells that maintains protein homeostasis (23-
26).
A crucial step during the programmed biosynthesis of aro-
matic polyketide natural products is the cyclization of the first
ring, catalyzed by the PT domains of the nrPKS (10, 27). This
event commits the highly reactive, pluripotent poly-β-ketoacyl











































































































































Fig. 1. Biosynthesis ofmonocillin II (1) and 10,11-dehydrocurvularin (2). (A)During the biosynthesis of the radicicol intermediatemonocillin II (1) in Chaetomium
chiversii (14), the hrPKS CcRADS1 produces a reduced pentaketide starter unit (13) that is transferred to the nrPKS CcRADS2 by the SAT domain (9) (step 1).
After a further four successive condensation events with malonyl-CoA (mCoA, step 2), catalyzed by the KS of the nrPKS CcRADS2, the linear ACP-bound
polyketide chain undergoes a C2-C7 aldol condensation catalyzed by the PT domain (10) (step 3). This condensation follows an F-type folding mode (28, 29). 1
is released by macrolactone formation catalyzed by the TE domain (2) (step 4). (B) Assembly of 2 in Aspergillus terreus AH-02-30-F7 also involves sequentially
acting collaborating iPKSs. However, the hrPKS AtCURS1 produces a reduced tetraketide starter, while the AtCURS2 PT domain catalyzes aldol condensation
in the C8-C3 register, following an S-type folding mode (28). C-C bonds in bold indicate intact acetate equivalents (malonate-derived C2 units) incorporated
into the polyketide chain by the iPKSs.
Fig. 2. Engineering first ring cyclization regiospecificity by domain replace-
ments.(A) Product profiles (HPLC traces recorded at 300 nm) of S. cerevisiae
BJ5464-NpgA(13, 34) co-transformed with YEpAtCURS1 and the indicated
YEpATCURS2 derivatives (SI Methods): (i) YEpATCURS2; (ii) YEpATCURS2-
ΔPT; (iii) YEpATCURS2-ΔPT+PTAtCURS2; (iv) YEpATCURS2-PTCcRADS2. The peak
in trace (i) labeled with the asterisk corresponds to 11-hydroxycurvularin,
a spontaneous hydration product of 2. (B) Product profiles (HPLC traces
recorded at 300 nm) of S. cerevisiae BJ5464-NpgA (13, 34) co-transformed
with YEpCcRADS1 and the indicated YEpCcRADS2 derivatives (SI Methods):
(i) YEpCcRADS2; (ii) YEpCcRADS2-ΔPT; (iii) YEpCcRADS2-ΔPT+PTCcRADS2; (iv)
YEpCcRADS2-PTAtCURS2. Polyketide products were characterized based on
their UV, ESI-MS, NMR and CD spectra, as well as Mosher’s method (see SI
Methodsfor details on isolation and chemical characterization).
chains towards defined structural classes of the possible polyke-
tide scaffold space. PT-catalyzed cyclizations most often follow an
F-type pattern whereby the benzene ring is assembled from two
intact malonate-derived C2 units and from two bridging carbons
from two additional acetate equivalents (28, 29) (Fig. 1). F-type
first ring cyclizations typically result from aldol condensations
Fig. 3. Fortuitous oxidation of isocoumarin 3 by S. cerevisiae BJ5464-NpgA.
(A) Product profiles (HPLC traces recorded at 300 nm) of S. cerevisiae BJ5464-
NpgA (13, 34) co-transformed with YEpAtCURS1 and YEpATCURS2-PTCcRADS2
and cultivated for the indicated amount of time. (B) HPLC analysis of the
bioconversion of 3 into 4 by S. cerevisiae BJ5464-NpgA.
in the C2-C7 (as in 1), C4-C9 or C6-C11 register. In contrast,
bacterial polyketide cyclase/aromatase enzymes (parts of Type II
PKS multienzyme complexes) typically direct an S-type folding
event whereby the carbons of the benzene ring are derived from
three intact malonate-derived C2 units (1, 28). Nevertheless, a
select few fungal polyketides, including DALs like 2 feature a
first ring connectivity that is analogous to the S-type folding
mode, resulting from an unorthodox C8-C3 aldol cyclization
event (20). The bacterial aromatase/cylcase enzymes show little
sequence similarity to fungal PT domains, and feature a different
protein fold and active site architecture as a prominent example
of convergent evolution (10, 30-32). The sequences of fungal PT
domains catalyzing F-type cyclization can be classified into seven
clades according to their regiospecificity and the length of their











































































































































Fig. 4. Homology models of PTCcRADS2 and
PTAtCURS2.Cartoon views of the homology models,
and stick representation of the amino acids lining
the cyclization chambers of (A, C) PTAtCURS2 and (B,
D) PTCcRADS2. The side chains of residues discussed
in the text are shown as golden sticks (catalytic
histidine), magenta sticks (residues implicated in
differentiating substrate orientation), and blue
sticks (other significant residues). Green sticks: The
substrate analog palmitic acid resident in the PTNSAS
structure 3HRQ (10).
Fig. 5. Reprogramming first ring cyclization regiospecificity by site directed
mutagenesis. (A) Proposed mechanism of regiospecific cyclizations catalyzed
by the PTAtCURS2 and the PTCcRADS2 domains. Enolate formation by depro-
tonation of C8 (AtCURS2) or C2 (CcRADS2) is promoted by the histidine
catalytic base, polarized by a conserved glutamic acid (AtCURS2: H1308 and
E1497, CcRADS2: H1325 and E1520). The substrates are proposed to thread via
alternate routes as directed by different gating residues at the entrance
of the cyclization chamber (AtCURS2: W1584, CcRADS2: L1609), and further
oriented by an inverted hydrophobic/H-bond donor residue pair lining the
rear end of the cyclization chamber (AtCURS2: F1455 and Y1576, CcRADS2:
Y1478 and F1601). (B) Product profiles (HPLC traces recorded at 300 nm) of S.
cerevisiae BJ5464-NpgA (13, 34) co-transformed with YEpAtCURS1 and the
YEpATCURS2 derivatives encoding the indicated PTAtCURS2 domain mutations
in AtCURS2.
the PT domain of the AtCURS2 curvularin synthase nrPKS is
firmly rooted in the C2-C7 clade of PTs which yield RALs like
1 (20). This result concurs with previous observations that fungal
iPKS evolve orthogonal product specificities primarily by point
mutations, and not by domain shuffling amongst distinct enzymes
(2).
The present work aimed to define how different regiospecific
outcomes for first ring cyclization are programmed into nrPKS
enzymes. By exploiting the orthogonal aldol condensation re-
giospecificities of the related PT domains of the nrPKSs for 1
and 2, we attempted to alter this program to switch F and S type
cyclization modes. Achieving precise control of regiospecificity
during the engineered biosynthesis of fungal polyketides is central
to producing biologically active “unnatural products”, and may
guide efforts to generate novel chemical diversity from natural
non-reduced fungal polyketides.
Results and Discussion
PTdomains are necessary for programmed polyketide formation.
Throughout this study, we have used an in vivo reconstituted
system for polyketide production, whereby recombinant hrPKS
+ nrPKS pairs are expressed from compatible plasmids in the
host Saccharomyces cerevisiae BJ5464-NpgA to produce 1 (9
mg/l, isolated yield), 2 (6 mg/l), and their derivatives (13, 34).
Deletion of PT domains has previously been shown in the Tang
and Townsend laboratories to yield shunt metabolites whose
backbones have undergone spontaneous cyclizations (12, 27, 29).
Thus, at the start of this work we considered it to be possible that
PTAtCURS2 is simply an inactive enzyme that does not contribute
to the folding of the nascent polyketide chain, and thus the DAL
scaffold of 2 is a serendipitous derailment product retained by
evolution. To exclude this possibility, we have deleted the PT
domain of AtCURS2 as well as the PT domain of CcRADS2,
the radicicol/monocillin II nrPKS of Chaetomium chiversii (14).
However, the corresponding yeast expression strains produced
no polyketides (Fig. 2). Complementation of the PT-less nrPKSs
with their dissected PT domains, expressed as separate ORFs in
trans, led to the rescue of the production of the native products











































































































































of this experiment contrasts previous in trans domain comple-
mentation attempts that did not yield observable products in
vivo (1, 29), and emphasizes that appropriate protein-protein
docking, substrate recognition and processing still can take place
with dissected domains expressed in heterologous hosts. Taken
together, these experiments show that the PT-less nrPKSs and the
freestanding PT domains are all catalytically active. The absence
of RAL/DAL product formation in the absence of PT domains
thus indicates that these domains fulfill an essential role in both
systems, and that un-templated poly-β-ketones are not released
by these nrPKSs.
Portability of aldol cyclization programs.Recent experiments
to replace PT domains in nrPKS model systems showed that the
register of F-type aldol condensations may be switched (29, 35),
with the incoming PTs enforcing a subtle shift of the substrate
chains in the catalytic chambers to expose different carbons (C2,
C4 or C6) to the catalytic histidine for deprotonation and enolate
formation (10). Thus, we were interested to see whether first
ring cyclizations may also be reconfigured between F- and S-type
folding modes by exchanging PT domains. This would require
radical re-routing of the polyketide substrate chain to expose a
carbon to the catalytic base that is distal (S-type) or proximal (F-
type) to the phosphopantetheine thioester. As shown above and
observed previously by others (1, 29, 36), in trans reconstitution
of iPKSs from dissected domains incurs a penalty for catalysis,
in terms of product yield and/or fidelity. Thus, we elected to
conduct these experiments with nrPKSs where the heterologous
PT domains replace their native equivalents in cis (29). Replace-
ment of the PT domain of AtCURS2 with PTCcRADS2 led to the
production of two isocoumarins, both resulting from C2-C7 aldol
cyclizations. The priming acyl chain of 3 (0.3 mg/l) corresponds
to the expected product of the hrPKS AtCURS1, while the major
product 4 (3 mg/l) features a carbonyl at C15 (Fig. 2A). The
formation of 3 and 4 indicates that PTCcRADS2 is able to process a
shorter substrate (an octaketide as opposed to its native nonake-
tide) while faithfully executing an F-type first ring closure. Time
course analysis of the fermentation with S. cerevisiae BJ5464-
NpgA [YEpAtCURS1 and YEpATCURS2-PTCcRADS2] (Fig. 3A)
shows that 3 is the primary product 24 hr after the induction of
polyketide production, but by 48 hr the formerly minor product 4
becomes dominant. Extending the cultivation to 72 hr and beyond
increased only the production of 4 but did not eliminate 3, nor
did it lead to the production of additional polyketide products.
Similarly, incubation of purified 3 with the untransformed yeast
host strain S. cerevisiaeBJ5464-NpgA led to the gradual, albeit not
complete, biotransformation of 3 to 4 (Fig. 3B). It was confirmed
that the untransformed yeast host strain does not produce 3 or 4,
nor is 3 converted to 4 by spontaneous oxidation in the culture
medium in the absence of yeast cells (Fig. 3B). Thus, 4 derives
from a chance oxidation of the 15-OH of 3 by an endogenous
enzyme of the yeast host.
The yeast strain co-expressing CcRADS1 and CcRADS2-
PTAtCURS2 yielded a novel compound (5, Fig. 2B), although with
a low productivity (0.3 mg/l). Structural characterization of this
product revealed that 5 harbors a novel carbon skeleton featuring
a C8-C3 dihydroxyphenylacetic acid moiety bridged by an 8-
membered lactone (SI Methods). Thus, PTAtCURS2 is competent
to process a longer substrate (a nonaketide as opposed to its
native octaketide) while retaining its ability to direct an S-type
folding and cyclization event. The 4-oxo-2-oxacyclooctanone ring
of 5 may be produced by the facile attack of the C1 carboxyl
on C11 of the enone; the involvement of the TE domain in this
reaction cannot be excluded at this point.
Collectively, these experiments show that the F- or S-type
regiospecificities of first ring cyclizations are solely programmed
into the PT domains of collaborating nrPKSs (29, 35). This pro-
gramming is portable amongst nrPKS platforms, without influ-
encing starter unit choice or the number of extensions carried out
by the rest of the chassis. The formation of the isocoumarins 3
and 4 and the 8-membered lactone 5 suggests that the nrPKS TE
domains may hydrolyze products with switched aldol condensa-
tion patterns, but they are unable to form a macrolactone using
a carbon chain with an isomeric fold. The low product yield of 5
suggests that CcRADS2 is a more stringent chassis, less amenable
to combinatorial replacement of its domains.
Homology models of PTAtCURS2 and PTCcRADS2. To identify
the structural basis of the programming of regiospecificity in PT
domains, we have created homology models of the PTAtCURS2 and
the PTCcRADS2 domains, based on the experimentally determined
structure of the PT domain of NSAS from Aspergillus parasiticus
(PTNSAS, PDB ID: 3HRR and 3HRQ) (10). The nrPKS NSAS
catalyzes the formation of norsorolinic acid, a C20 polyketide
primed with hexanoic acid, with the PTNSAS directing an F-type
folding mode first ring cyclization event (28) in the C4-C9 regis-
ter, followed by a second ring closure at C2-C11.
In spite of relatively low sequence similarities with PTNSAS
(PTAtCURS2: 22% identity and 41% similarity; PTCcRADS2: 20%
identity and 40% similarity), combined structural evaluation and
fold recognition scores of 3.6 (PTCcRADS2) and 3.47 (PTAtCURS2)
obtained from the reliability assessment engine PCONS5 (37)
indicated that the fold recognition is reliable for both PTAtCURS2
and PTCcRADS2 (a PCONS score > 2.17 is considered reliable,
a score > 1.5 is considered significant). PTNSAS features a long,
straight cyclization chamber and a hydrophobic hexyl-binging
region that accommodates the starter unit, with the substrate
bound in an extended conformation (10). In contrast, homology
modeling had suggested that PKS4, the zearalenone nrPKS from
Gibberella fujikuroi (10, 16, 38) contains a PT domain with a
wider, curved catalytic chamber where the substrate adopts a bent
conformation (10). Similar to the model proposed for PTPKS4, the
hydrophobic hexyl-binding region present in PTNSAS was found to
be closed off in both PTAtCURS2 and PTCcRADS2 by the bulky side
chains of two phenylalanine residues (Fig. 4). First, a replacement
of M1495 of NSAS by phenylalanine (AtCURS2: F1449, CcRADS2:
F1472) narrows the hexyl-binding region. Next, the side chain of
another phenylalanine residue in place of G1491 (AtCURS2: F1445,
CcRADS2: F1468) directly clashes with the tail of the palmitic acid
that occupies this pocket in structure 3HRR. This latter pheny-
lalanine is also conserved not only in all other RAL PT domains
(14-16, 38), but also in clades II, III and V of characterized PT
domains (29). Thus, the hrPKS-derived reduced acyl chains of
the nascent intermediates for 1 and 2 may not be sequestered in
a deep, buried pocket (10) in these enzymes.
The RAL/DAL PT models retain the large substrate binding
chamber where cyclization occurs (10). This cyclization chamber
appears constricted at the residues corresponding to V1347 and
A1397 of NSAS (AtCURS2: M1310 and P1356, CcRADS2: M1327 and
P1374) but this is compensated by substitutions with less bulky
side chains corresponding to P1355 and W1571 (AtCURS2: G1318
and F1524, CcRADS2: G1335 and F1550, Fig. 4). The cyclization
chamber is proposed to feature an active site dyad (AtCURS2:
H1308, E1497; CcRADS2: H1325, E1520) where the aspartic acid
(D1543) that polarizes the catalytic base (H1345) in NSAS is re-
placed by glutamic acid. This functionally conserved replacement
is present in all known RAL and DAL PT domains (14-16, 38),
but not in clades II-V of functionally characterized PT domains
(29). The same D to E replacement is nonetheless common in
dehydratases with a fold similar to those of PT domains, and was
also found in some Type II PKS aromatase/cyclase enzymes (32).
After deprotonation of C8 (AtCURS2) or C2 (CcRADS2) by the
catalytic base, the enolate intermediate is thought to be stabilized
by the backbone amine of V1521 (AtCURS2) or N1547 (CcRADS2)











































































































































carbonyl, the oxyanion may be stabilized by a network of water
molecules that are coordinated in NSAS by S1356, D1543, T1546 and
N1568. Only some of these residues are conserved in AtCURS2
(S1319, E1497, V1500, and V1521) and CcRADS2 (S1336, E1520, V1523,
and N1547), and similar replacements are also present in all RAL
PT domains (14-16, 38). The second half of the oxyanion hole is
provided by the backbone amine of a glycine in DH domains and
hydratases with which PT domains share a double hot dog fold
and a proposed evolutionary origin (10). For NSAS, this glycine
was seen to be replaced by P1355, but this residue is restored to
glycine in all known RAL PT domains (14-16, 38) (AtCURS2:
G1318; CcRADS2: G1335). The corresponding position is occu-
pied by serine in clades II, III and V of PT domains (29). The
electrophilic carbonyl that takes part in the aldol cyclization is
polarized via hydrogen bonding through the same water network,
while hydrogen bonding with an asparagine that is conserved in
all functionally characterized PT domains (29) may help to orient
the substrate in the chamber (NSAS: N1554; AtCURS2: N1508,
CcRADS2: N1531).
Conversion of S- and F-type folding modes by structure-
based site-directed mutagenesis. A superimposition of the mod-
els for PTAtCURS2 and PTCcRADS2 (47% sequence identity and 65%
similarity) showed that the active sites and the cyclization cham-
bers of these two enzymes are highly conserved. Nevertheless,
PTAtCURS2 forms a first ring in the C8-C3 register with a folding
mode analogous to the S-type, while PTCcRADS2 catalyzes an F-
type folding mode (28) first ring closure in the C2-C7 register.
We have identified three key differences that we hypothesized
would result in a change in substrate orientation in the binding
pocket, and lead to the orthogonal cyclization regiospecificities
observed in 1 vs. 2 (Fig. 5A). First, L1609 of PTCcRADS2 is re-
placed by W1584 near the substrate entrance in PTAtCURS2. The
bulky side chain of this tryptophan narrows the entrance of the
cyclization chamber of PTAtCURS2, and may serve to direct C2
of the penetrating acyl chain away from the catalytic histidine.
Leucine is strictly conserved at this position in all characterized
RALPTs (14-16, 38) and predominates (withmethionine as an al-
ternative) in clade II-V PTs catalyzing various F-type cyclizations
(29). Next, both PTAtCURS2 and PTCcRADS2 (as well as all other
characterized RAL PTs (29)) display a tyrosine-phenylalanine
residue pair on opposing faces at the rear of the binding pocket.
Remarkably, these residues are inverted in PTAtCURS2 vs. all
known RAL PT domains (PTAtCURS2: F1455 and Y1576, PTCcRADS2:
Y1478 and F1601). By participating in hydrogen bond networks (Y)
or by contributing to a hydrophobic surface of the pocket (F),
these residues may help to position the chain such that either
C8 (PTAtCURS2) or C2 (PTCcRADS2) would be presented to the
catalytic base (PTAtCURS2: H1308, PTCcRADS2: H1325), leading to
S-type (PTAtCURS2) or F-type (PTCcRADS2) cyclization outcomes.
Notably, all three distinguishing residues (W1584, F1455 and Y1576)
are conserved between PTAtCURS2 and the PT domain of an
orphan hrPKS-nrPKS system in the genome ofPyrenophora tritici-
repentis PT-1C-BFP (GenBank: EDU47225 and EDU47223):
this putative DAL synthase is the closest ortholog of the dehy-
drocurvularin synthase AtCURS1-AtCURS2 (20). Although the
highlighted residues are positioned such that substrate binding
is expected to be affected, verification of the specific contacts
must await the determination of the crystal structures of these
domains with bound substrates/products. In the meantime, these
three residues may serve as distinguishing sequence signatures to
predict RAL vs. DAL formation by orphan biosynthetic systems
found in sequenced fungal genomes.
To test our structural analysis, we systematically replaced
one, two or all three of the identified residues (F1455, Y1576,
and W1584) in AtCURS2 with their counterparts of CcRADS2,
and co-expressed these enzymes with AtCURS1 in yeast. Single
mutations did not alter the regiospecificity of first ring closure
in the product (Fig. 5B). Double mutations either eliminated
product formation (F1455Y + W1584L), or yielded a mixture of 2
and 4, indicating a relaxed aldol condensation regiospecificity for
some of these mutant enzymes. Finally, the enzyme with all three
mutations produced only 3 and 4 (0.2 and 2 mg/l, respectively),
with no detectable 2. Thus, these three selected point mutations
were sufficient to completely transform the native C8-C3 (S-type)
regiospecificity of PTAtCURS2 to C2-C7 (F-type, Fig. 5B). The con-
verse experiment (replacing Y1478, F1601 and L1609 in CcRADS2
with the corresponding residues ofAtCURS2 in all combinations)
reduced the yield or completely eliminated the production of
1, but did not provide 5 or any other detectable C8-C3 DAL
(Fig. S1). The absence of the expected product may not be
surprising if we consider the low yield of 5 even with CcRADS2-
PTAtCURS2, where the incoming PTAtCURS2 domain has presumably
been optimized by evolution for the effective synthesis of C8-C3
products. A similar recalcitrance to alteration of stereocontrol
has been noted for KR and ER domains during site-directed
mutagenesis (but not during complete domain exchanges) in the
context of modular PKS systems. Presumably, any proofreading
activity from downstream domains (e.g. the TE in our system)
may override the effects of subtle alterations of the active site
architecture (3, 39, 40).
The current work affirms that first ring cyclization regiospeci-
ficity in fungal collaborating iPKSs is programmed in the com-
position and geometry of the cyclization chambers of the PT
domains. Exploiting structural information on PT domains, we
have gained insight into the origins of the programming of this
folding specificity. Replacement of just three select residues of
the product cyclization chambers in a keyhole surgery-like ap-
proach converted a PT domain from an atypical, C8-C3-specific,
S-type folding mode cyclase into a typical, C2-C7-selective, F
type folding mode enzyme, as predicted. The identified signa-
ture residues may be used to predict polyketide folding modes
in orphan RAL/DAL biosynthetic systems. More importantly,
rational reprogramming of polyketide folding modes in fungal
iPKSs opens new possibilities for the engineered biosynthesis of
novel unnatural polyketides with isomeric folds, including cancer
cell proliferation inhibitors and immune system modulators.
Materials and Methods
Strains and Culture Conditions. E. coli DH10B and plasmid pJET1.2 (Fermen-
tas) were used for routine cloning and sequencing. Saccharomyces cerevisiae
BJ5464-NpgA (MATα ura3-52 his3-Δ200 leu2-Δ1 trp1 pep4::HIS3 prb1 Δ1.6R
can1 GAL) (34, 41) was maintained on yeast extract peptone dextrose agar
(YPD, Difco), and transformed using the small scale lithium chloride protocol
(42). The yeast – E. coli shuttle vectors YEpADH2p-FLAG-URA and YEpADH2p-
FLAG-TRP (20) are based on the YEpADH2p vectors with the URA3 or with
the TRP1 selectable markers (13). Primers used in this study are listed in Table
S2. Details on the construction of gene variants and expression constructs are
described in the SI Methods. For each recombinant yeast strain, three to five
independent transformants were analyzed for the production of polyketides
by small scale fermentation, and fermentations with representative isolates
were repeated at least three times to confirm results.
Small scale fermentation and analysis of products. Yeast strains were
cultured in 50 mL of SC medium (0.67% yeast nitrogen base, 2% glucose,
and 0.72 g/L Trp/Ura DropOut supplement) at 30 °C with shaking at 250
rpm. When the OD600 reached 0.6, an equal volume of YP medium (1%
yeast extract, 2% peptone) was added to the cultures, and the fermentation
was continued at 30 °C with shaking at 250 rpm for an additional 2 days.
The cultures were adjusted to pH 5.0, and extracted with equal volumes of
ethyl acetate three times. The collected organic extracts were evaporated to
dryness and analyzed by reversed phase HPLC (Kromasil C18 column, 5 µm,
4.6 mm × 250 mm; eluted with 5% aqueous acetonitrile for 5 min, followed
by a linear gradient of 5-95% CH3CN over 10 min, and 95% CH3CN for 10
min at a flow rate of 0.8 mL/min; detection at 300 nm). Analysis of the
time course of the production of 3 and 4, biotransformation of 3 to 4 by
Saccharomyces cerevisiae BJ5464-NpgA, and scale-up of fermentations and












































































































































Chemical characterization of polyketide products. Optical rotations
were recorded on a Rudolph Autopol IV polarimeter with a 10-cm cell. CD
spectrawere acquiredwith a JASCO J-810 instrument using a path length of 1
cm. 1H, 13C, and 2D NMR (COSY, HSQC, HMBC, ROESY) spectra were recorded
in DMSO-d6, CD3OD or C5D5N on a JEOL ECX-300 spectrometer. ESI-MS data
were collected on an Agilent 6130 Single Quad LC-MS. See SI Methods for
details.
Homology Modeling. Sequences of the PTAtCURS2 and PTCcRADS2 domains
were submitted to the BioInfoBank Meta Server (3DJury) (43). Models based
upon the Research Collaboratory for Structural Bioinformatics (RCSB) Protein
Data Bank PKsA structures 3HRQ and 3HRR (10) were generated by several
homology modeling servers. Carbon-alpha models generated by the SAM-
HMM server (44) were ranked by 3DJury as most representative and chosen
for use. All atom models were created using MODELLER (45). There were
no significant differences between the models based upon 3HRQ and those
based upon 3HRR. PCONS5 (37) was used to evaluate fold recognition.
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